Latest News
Latest News
FDA approves corticosteroid-retinoid lotion for plaque psoriasis
The treatment combines halobetasol and tazarotene.
News
FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasis
More than half of patients had total skin clearance after a year of risankizumab treatment.
News
TNF-alpha, adiponectin potential biomarkers for PsA, psoriasis differentiation
The two markers can potentially differentiate the two psoriasis types.
News
Survey finds psoriasis patients seek relief with alternative therapies
The majority said they used complementary and alternative medicines because “traditional medications did not help or had side effects.”
News
AFib, CVD risks similar after ustekinumab and TNF inhibitors in psoriatic patients
Further studies are needed to stratify patients by important risk factors, investigators wrote.
News
Proinflammatory diet may not trigger adult psoriasis, PsA, or AD
Proinflammatory foods included processed meat, red meat, organ meat, vegetables other than leafy green and dark yellow, refined grains, low- and...
Conference Coverage
TNF inhibitor–induced psoriasis in IBD patients a consideration
WASHINGTON –This is a paradoxical reaction, which can happen “weeks to years after starting a TNF blocker”.
News
Herpes zoster risk increased with some psoriasis, psoriatic arthritis treatments
Patients with psoriasis and psoriatic arthritis may be at an increased risk of herpes zoster, particularly those treated with tofacitinib or...
Conference Coverage
Immunomodulators for pediatric skin diseases
WASHINGTON – Pediatric dermatologist A. Yasmine Kirkorian, MD, provides clinical pearls and practical considerations on the use of...
News
FDA approves patient-controlled injector for guselkumab
The Food and Drug Administration has